Peptides / Cagrilintide / United States
Cagrilintide in the United States
Legal status, what it is, and the listed suppliers in the United States that list it.
Legal status in the United States
Not an approved medicine. Investigational.
As understood at 2026-09-22. Verify with the FDA.
What Cagrilintide is
Cagrilintide is a long-acting synthetic analogue of amylin, a 37-amino-acid hormone released alongside insulin that slows stomach emptying and signals fullness. Developed by Novo Nordisk, it is mostly studied in combination with semaglutide under the name CagriSema. It is an investigational drug and not yet licensed anywhere.
Listed suppliers in the United States
6 of the 10 suppliers we list in the United States list Cagrilintide. Listed, not endorsed: each row is the supplier’s own stated terms.
American Peptides
United States
Products are sold for Research Use Only and not for Human Consumption. Not for human or veterinary use.
Direct Peptides
United States
All products are sold strictly for laboratory research use only and are not for human or animal consumption. Direct Peptides is a chemical supplier, not a compounding pharmacy or 503A/503B facility.
Licensed Peptides
United States
Supplied strictly for laboratory research use only. Not intended for human consumption, veterinary use, therapeutic applications, or diagnostic use. No dosing instructions are provided.
Nationwide Peptides
United States
For Research Use Only. Products are not intended for human or animal consumption, ingestion, injection, or any form of administration.
Peak Lab Peptides
United States
All products on this site are for research and development use only. Products are not for human consumption of any kind.
Protide Health
United States
All products are supplied for laboratory research only and are not for human or animal consumption, medical use, veterinary use, or any therapeutic, diagnostic, or clinical purpose.